Cargando…
The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of age
BACKGROUND: Over 200 million individuals worldwide are infected with Schistosoma species, with over half of infections occurring in children. Many children experience first infections early in life and this impacts their growth and development; however praziquantel (PZQ), the drug used worldwide for...
Autores principales: | Webb, Emily L., Edielu, Andrew, Wu, Hannah W., Kabatereine, Narcis B., Tukahebwa, Edridah M., Mubangizi, Alfred, Adriko, Moses, Elliott, Alison M., Hope, William W., Mawa, Patrice A., Friedman, Jennifer F., Bustinduy, Amaya L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419815/ https://www.ncbi.nlm.nih.gov/pubmed/34488846 http://dx.doi.org/10.1186/s13063-021-05558-1 |
Ejemplares similares
-
Regression of Schistosoma mansoni associated morbidity among Ugandan preschool children following praziquantel treatment: A randomised trial
por: Nalugwa, Allen, et al.
Publicado: (2021) -
Performance and Safety of Praziquantel for Treatment of Intestinal Schistosomiasis in Infants and Preschool Children
por: Sousa-Figueiredo, José C., et al.
Publicado: (2012) -
Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration
por: Crellen, Thomas, et al.
Publicado: (2016) -
Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial
por: Nalugwa, Allen, et al.
Publicado: (2015) -
Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda
por: Faust, Christina L., et al.
Publicado: (2019)